MedPath

Effects of Personalized Training Program on Coronary Flow Reserve in Healthy Volunteers

Not Applicable
Conditions
Coronary Artery Disease
Heart Infarction
Interventions
Behavioral: physical exercise
Behavioral: limited physical exercise
Registration Number
NCT02713724
Lead Sponsor
Göteborg University
Brief Summary

This study investigates whether an individualized exercise program, including a personal trainer, can improve cardiovascular status quantified with ultrasound to assess coronary flow reserve and other non-invasive techniques. The subjects in the study will be divided into two groups; one group will have a personalized exercise- and nutrition program and the other group will have acess to a gym membership, but no personal trainer.

Detailed Description

Coronary heart disease is one of our most common diseases that causes significant morbidity and mortality. Because the risk of serious cardiovascular events, such as myocardial infarction and death, is evident in this patient population, it is of utmost importance to develop diagnostic methods to identify patients at risk. The most appropriate diagnostic methods are those that are safe to implement for both patient and physician, but also accessible and cost-efficient.

By using non-invasive techniques such as ultrasound, coronary artery function can be examined as coronary flow reserve (CFR). In the platform of non-invasive techniques used by the investigators for examinations of cardiovascular status, other methods are included, such as measurement of intima-media thickness in the carotid and radial arteries. The investigators goal is to compare the group with the personalized program with its placebo, and to compare the two study-groups with each other, to investigate whether the personalized program provides greater health benefits.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • non-smokers
  • no current medication,
  • no known diseases that require regular medication
  • no known risk factor for cardiovascular disease (hypertension, hyperlipidemia, diabetes, heredity, obesity, peripheral vascular disease)
  • no physically fit athletes.
Exclusion Criteria
  • ongoing treatment with medicine containing dipyridamole (asasantin, persantin)
  • known hypersensitivity to adenosine
  • chronic obstructive pulmonary disease
  • atrial fibrillation or other obvious arrythmias
  • AV-block grade 2 or higher
  • other serious illness

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
DAPS-groupphysical exercisePhysical exercise
Standard-grouplimited physical exerciseLimited physical exercise
Primary Outcome Measures
NameTimeMethod
Coronary flow reserve (CFR)3-6 months

Ultrasound-assessed coronary flow reserve. Data will be presented as a ratio (no unit) between maximal mean hyperemia flow velocity and baseline velocity

Secondary Outcome Measures
NameTimeMethod
endothelial function3-6 months

measured by EndoPath-device as RHI (reactive hyperemic index). Data will be presented as number of patients with abnormal RHI-values

cIMT (carotid artery intima-media thickness)3-6 months

carotid artery intima-media thickness, data will be presented in mm

cardiovascular biomarkers3-6 months

relevant cardiovascular blood biomarkers, data will be presented as numbers of participants with values of laboratory analyses below or above reference values

metabolic biomarkers3-6 months

relevant metabolic blood biomarkers, data will be presented as numbers of participants with values of laboratory analyses below or above reference values

QoL (quality of life)3-6 months

quality of life as measured by the validated scale PGWB (personal general well-being scale). Data will be presented as scores from the scale.

Trial Locations

Locations (1)

Sahlgrenska University Hospital

🇸🇪

Gothenburg, VG-region, Sweden

© Copyright 2025. All Rights Reserved by MedPath